ATS Medical Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced that a total of 47 patients have now undergone aortic valve replacement with its sutureless ATS 3f Enable(TM) Aortic Bioprosthesis at seven investigative sites in Europe within both the feasibility and pivotal clinical trial phases. Currently, eight patients have [...]